Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.
Faculty of Sciences, Yarmouk University, Irbid 21163, Jordan.
Nutrients. 2023 Jun 9;15(12):2692. doi: 10.3390/nu15122692.
The aim of this study was to investigate the potential antidepressant and anxiolytic effects of vitamin C and vitamin D in a stress-induced mouse model of depression, while also exploring the association between these effects and the levels of circulating NOx, periostin, and FKBPL. Our findings revealed that both vitamin C and vitamin D exhibited comparable antidepressant effects to escitalopram, a commonly used antidepressant, without demonstrating any anxiolytic effects. The antidepressant properties of vitamin C and vitamin D were linked to the normalization of Nox and FKBPL levels, while the levels of periostin showed no significant correlation. These results are consistent with previous research, indicating that the antidepressant effects of vitamin C and vitamin D may be attributed to their antioxidant and anti-inflammatory properties, as well as their modulation of neurotransmission and norepinephrine release. Additionally, our study uncovered elevated levels of periostin in stress-induced depression, which were only restored to normal levels by escitalopram, suggesting a potential role for periostin in mood disorders. Furthermore, FKBPL and NOx levels were increased in stress-induced depression and normalized by treatment with vitamin C, vitamin D, and escitalopram, indicating their involvement in the stress response and gene expression regulation. However, it is important to acknowledge certain limitations of our research, such as the use of a single depression induction model and limited dosing regimens. Future investigations should focus on examining these markers in specific brain regions, such as the hippocampus and prefrontal cortex, to gain a more comprehensive understanding of their potential implications for depression. Overall, our findings suggest that vitamin C, vitamin D, and escitalopram may possess antidepressant properties mediated by NOx and FKBPL levels, while emphasizing the potential significance of periostin in the context of depression.
本研究旨在探讨维生素 C 和维生素 D 在应激诱导的抑郁小鼠模型中的潜在抗抑郁和抗焦虑作用,同时探索这些作用与循环 NOx、periostin 和 FKBPL 水平之间的关联。我们的研究结果表明,维生素 C 和维生素 D 均表现出与 escitalopram(一种常用的抗抑郁药)相当的抗抑郁作用,而没有表现出任何抗焦虑作用。维生素 C 和维生素 D 的抗抑郁特性与 Nox 和 FKBPL 水平的正常化有关,而 periostin 水平则没有显著相关性。这些结果与先前的研究一致,表明维生素 C 和维生素 D 的抗抑郁作用可能归因于其抗氧化和抗炎特性,以及它们对神经递质和去甲肾上腺素释放的调节作用。此外,我们的研究发现应激诱导的抑郁症中 periostin 水平升高,而 escitalopram 仅能将其恢复到正常水平,提示 periostin 可能在情绪障碍中发挥作用。此外,应激诱导的抑郁症中 FKBPL 和 NOx 水平升高,经维生素 C、维生素 D 和 escitalopram 治疗后恢复正常,表明它们参与了应激反应和基因表达调控。然而,需要承认我们的研究存在一定的局限性,例如使用单一的抑郁症诱导模型和有限的剂量方案。未来的研究应重点研究这些标志物在特定脑区(如海马体和前额叶皮层)中的作用,以更全面地了解它们在抑郁症中的潜在意义。总的来说,我们的研究结果表明,维生素 C、维生素 D 和 escitalopram 可能具有抗抑郁作用,其机制与 NOx 和 FKBPL 水平有关,同时强调了 periostin 在抑郁症中的潜在重要性。